Drug Eluting Balloons Market: Innovation in Vascular Therapy
Drug eluting balloons represent a breakthrough in minimally invasive vascular treatments. These devices deliver therapeutic agents directly to affected blood vessels during angioplasty, reducing restenosis without leaving permanent implants.
They are particularly valuable in treating peripheral artery disease and complex coronary lesions. By combining mechanical dilation with targeted drug delivery, outcomes are improved while procedural complexity is reduced.
Ongoing innovation focuses on drug formulations, coating technologies, and balloon designs to enhance efficacy. Clinicians increasingly adopt these solutions for personalized vascular care.
Drug eluting balloons exemplify the convergence of device engineering and pharmacology in modern interventional medicine.